CBD improved astrocyte energy metabolism and reduced inflammation in a cell model of neurotoxicity, with CB1 receptors playing a key role in the anti-inflammatory response.
Neuroscientists, neuroinflammation researchers, and CBD pharmacology scientists.
CB1-dependent glycolysisCBD shifted astrocyte energy metabolism toward glycolysis while reducing inflammation through CB1 receptor mechanisms
What the researchers found
CBD decreased mitochondrial proton leak, increased spare respiratory capacity, and enhanced glycolytic capacity in inflamed astrocytes while reducing pro-inflammatory cytokines TNFα and IL-6 and ROS production, partly through CB1-dependent mechanisms.
Why it matters
Understanding how CBD protects brain support cells (astrocytes) from inflammatory damage could inform treatments for neurodegenerative diseases where inflammation and metabolic dysfunction are key drivers.
The numbers in context
CBD reduced TNFα and IL-6 concentrations and ROS production in LPS-stimulated astrocytes. Glycolytic changes were CB1-dependent. CB1 antagonist SR141716A increased pro-inflammatory cytokines and ROS.
How the study worked
In vitro study using primary astrocyte cell cultures stimulated with LPS (lipopolysaccharide). Metabolic profiling with extracellular flux analyzer. CB1 involvement assessed with receptor antagonist.
Who was studied
Primary astrocyte cell cultures in an LPS-induced neurotoxicity model.
What this study cannot tell us
In vitro cell culture model does not replicate in vivo brain complexity. LPS stimulation is a simplified inflammatory model. CBD concentrations used may not match achievable brain levels.
How to read the evidence
In vitro mechanistic study providing detailed pathway analysis; requires in vivo validation.
When this study was published
Recent in vitro study on CBD neuroprotective mechanisms.
The bigger picture
This study adds mechanistic detail to how CBD exerts neuroprotection, showing it works by shifting astrocyte energy metabolism from oxidative phosphorylation toward glycolysis while dampening inflammatory responses.
Replication
In vitro study; in vivo validation needed for clinical relevance.
Funding
Not specified in abstract
Conflicts of interest
Not specified in abstract
Questions still open
- Would these metabolic effects translate to neuroprotection in animal models?
- Is the CB1-dependent glycolytic shift a general mechanism or specific to astrocytes?
Read the original research
Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors.
Neurotoxicity research, 41(6), 615-626
Citation
Ibork, Hind; Idrissi, Sara El; Zulu, Simo Siyanda; Miller, Robert; Hajji, Lhoussain; Morgan, Annabelle Manalo; Taghzouti, Khalid; Abboussi, Oualid. (2023). Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors.. Neurotoxicity research, 41(6), 615-626. https://doi.org/10.1007/s12640-023-00671-2